Literature DB >> 6423288

Analogs that compete for antigen binding to an arsonate-reactive T-cell clone inhibit the functional response to arsonate.

A Rao, S J Faas, H Cantor.   

Abstract

We have tested several structurally related haptens, conjugated to ovalbumin, for their effect on activation of an inducer T-cell clone reactive to the p-azobenzenearsonate (arsonate) hapten. Low concentrations of some analogs inhibited DNA synthesis and lympkokine production by the clone in response to arsanylated antigen, but not in response to the lectin concanavalin A. Inhibition was specific for this clone, since the response of clones reactive to other antigens was not blocked. Inhibition may result from competition of these analogs with arsonate at a site on the T cell. The effectiveness of blocking by arsonate analogs parallels their ability to bind to a previously described arsonate-binding site on the clone (Rao et al., accompanying paper). We suggest that the binding and blocking assays detect the same physiological arsonate-recognition site on the clone, and hence that the cell-surface arsonate-binding sites we have described mediate its physiological response to antigen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423288     DOI: 10.1016/0092-8674(84)90038-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  6 in total

Review 1.  Antigen-major histocompatibility complex-T cell receptors: inquiries into the immunological ménage à trois.

Authors:  J Klein
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

2.  A solubilized T-cell receptor from a human leukemia cell line binds to a ligand in the absence of MHC products.

Authors:  J D Fraser; J L Strominger
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Functional analysis of the antigen binding site on the T cell receptor alpha chain.

Authors:  E A Nalefski; S Kasibhatla; A Rao
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

4.  Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands.

Authors:  G J Kersh; P M Allen
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

5.  Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor.

Authors:  A R Hamad; S M O'Herrin; M S Lebowitz; A Srikrishnan; J Bieler; J Schneck; D Pardoll
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

6.  Inhibition or activation of human T cell receptor transfectants is controlled by defined, soluble antigen arrays.

Authors:  D E Symer; R Z Dintzis; D J Diamond; H M Dintzis
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.